SAN DIEGO, May 7 /PRNewswire/ -- Drawing on the record of one of the oldest and most successful models of health screening, the Cervical Pap Test, NeoMatrix will showcase its Halo(TM) Breast Pap Test System, the first automatic, noninvasive test of its kind, here at the 55th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), May 5-9, 2007. Designed to detect abnormal cells in the breast years earlier than a lesion might be found on a mammogram or a clinical breast exam, the HALO System facilitates the identification of benign breast disease. A recent article in the New England Journal of Medicine identified benign breast disease an important risk factor for breast cancer.
